The care of patients with oesophageal cancer or of individuals who have an elevated risk of
oesophageal cancer has changed dramatically. The epidemiology of squamous cell and …

Multidisciplinary treatment for esophageal cancer leads to nutritional and inflammatory
changes. Recent studies showed that nutritional and inflammatory changes during …

PURPOSE Preoperative chemoradiotherapy according to the chemoradiotherapy for
esophageal cancer followed by surgery study (CROSS) has become a standard of care for …

Background No adjuvant treatment has been established for patients who remain at high
risk for recurrence after neoadjuvant chemoradiotherapy and surgery for esophageal or …

PURPOSE To develop recommendations involving targeted therapies for patients with
advanced gastroesophageal cancer. METHODS The American Society of Clinical Oncology …

PURPOSE Patients with advanced or metastatic esophageal squamous cell carcinoma
(ESCC) have poor prognosis. For these patients, treatment options are limited after first-line …

Neoadjuvant chemoimmunotherapy (NACI) has shown promise in the treatment of
resectable esophageal squamous cell carcinoma (ESCC). The microbiomes of patients can …

Background Large studies comparing totally minimally invasive oesophagectomy (TMIE)
with laparoscopically assisted (hybrid) oesophagectomy are lacking. Although randomized …

Background To evaluate the efficacy and safety of toripalimab combined with neoadjuvant
chemoradiotherapy (NCRT) for locally advanced esophageal squamous cell carcinoma …

Background & aims Malnutrition has been reported to lead to poor postoperative outcomes.
The Global Leadership Initiative on Malnutrition (GLIM) criteria were published in 2019 as a …